NOVEL COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

This present invention relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1) antagonist; and a pharmaceutical composition containing the same. The present invention provides a pharmaceutical composition for pr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KIM, HEE-DOO, PARK, SEOL RIN, KIM, SUNG-IL, LEE, KI-WHA, MOH, JOO HYUN, LIM, KYUNG MIN, WOO, BYOUNG YOUNG, CHOI, JIN KYU, KIM, JOO HYUN, SUH,YOUNG-GER, JEONG, YEON SU, KIM, JIN KWAN, KOH, HYUN JU, JANG, MI JUNG, KIM, SUN-YOUNG, PARK, HYEUNG-GEUN, OH, UH TAEK, SHIN, SONG SEOK, PARK, YOUNG-HO
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator KIM, HEE-DOO
PARK, SEOL RIN
KIM, SUNG-IL
LEE, KI-WHA
MOH, JOO HYUN
LIM, KYUNG MIN
WOO, BYOUNG YOUNG
CHOI, JIN KYU
KIM, JOO HYUN
SUH,YOUNG-GER
JEONG, YEON SU
KIM, JIN KWAN
KOH, HYUN JU
JANG, MI JUNG
KIM, SUN-YOUNG
PARK, HYEUNG-GEUN
OH, UH TAEK
SHIN, SONG SEOK
PARK, YOUNG-HO
description This present invention relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1) antagonist; and a pharmaceutical composition containing the same. The present invention provides a pharmaceutical composition for preventing or treating a disease such as pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorder, urinary bladder hypersensitiveness, irritable bowel syndrome, fecal urgency, a respiratory disorder, irritation of skin, eye or mucous membrane, stomach-duodenal ulcer, inflammatory diseases, ear disease, and heart disease.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP1861357A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP1861357A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP1861357A13</originalsourceid><addsrcrecordid>eNqNjT0KwkAQhdNYiHqHuYBFCP6A1biZJAubmSW7CViFIGslGogn8cSuaGVlNe_B976ZJ0-Wjgwoqa20nDuQBmyFTY2KWq8VGnMCVIqsx6MhcGi8A19RQ1IAOuiQtTGic2joTcU9ssdSWDt_iDn_8X1-Oe21sIslwpo1l29p1Ne0TGaX4TqF1fcuEijIq2odxnsfpnE4h1t49GTT_TbNNjtMsz-QF6XeQTc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NOVEL COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME</title><source>esp@cenet</source><creator>KIM, HEE-DOO ; PARK, SEOL RIN ; KIM, SUNG-IL ; LEE, KI-WHA ; MOH, JOO HYUN ; LIM, KYUNG MIN ; WOO, BYOUNG YOUNG ; CHOI, JIN KYU ; KIM, JOO HYUN ; SUH,YOUNG-GER ; JEONG, YEON SU ; KIM, JIN KWAN ; KOH, HYUN JU ; JANG, MI JUNG ; KIM, SUN-YOUNG ; PARK, HYEUNG-GEUN ; OH, UH TAEK ; SHIN, SONG SEOK ; PARK, YOUNG-HO</creator><creatorcontrib>KIM, HEE-DOO ; PARK, SEOL RIN ; KIM, SUNG-IL ; LEE, KI-WHA ; MOH, JOO HYUN ; LIM, KYUNG MIN ; WOO, BYOUNG YOUNG ; CHOI, JIN KYU ; KIM, JOO HYUN ; SUH,YOUNG-GER ; JEONG, YEON SU ; KIM, JIN KWAN ; KOH, HYUN JU ; JANG, MI JUNG ; KIM, SUN-YOUNG ; PARK, HYEUNG-GEUN ; OH, UH TAEK ; SHIN, SONG SEOK ; PARK, YOUNG-HO</creatorcontrib><description>This present invention relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1) antagonist; and a pharmaceutical composition containing the same. The present invention provides a pharmaceutical composition for preventing or treating a disease such as pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorder, urinary bladder hypersensitiveness, irritable bowel syndrome, fecal urgency, a respiratory disorder, irritation of skin, eye or mucous membrane, stomach-duodenal ulcer, inflammatory diseases, ear disease, and heart disease.</description><language>eng ; fre ; ger</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20071205&amp;DB=EPODOC&amp;CC=EP&amp;NR=1861357A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20071205&amp;DB=EPODOC&amp;CC=EP&amp;NR=1861357A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KIM, HEE-DOO</creatorcontrib><creatorcontrib>PARK, SEOL RIN</creatorcontrib><creatorcontrib>KIM, SUNG-IL</creatorcontrib><creatorcontrib>LEE, KI-WHA</creatorcontrib><creatorcontrib>MOH, JOO HYUN</creatorcontrib><creatorcontrib>LIM, KYUNG MIN</creatorcontrib><creatorcontrib>WOO, BYOUNG YOUNG</creatorcontrib><creatorcontrib>CHOI, JIN KYU</creatorcontrib><creatorcontrib>KIM, JOO HYUN</creatorcontrib><creatorcontrib>SUH,YOUNG-GER</creatorcontrib><creatorcontrib>JEONG, YEON SU</creatorcontrib><creatorcontrib>KIM, JIN KWAN</creatorcontrib><creatorcontrib>KOH, HYUN JU</creatorcontrib><creatorcontrib>JANG, MI JUNG</creatorcontrib><creatorcontrib>KIM, SUN-YOUNG</creatorcontrib><creatorcontrib>PARK, HYEUNG-GEUN</creatorcontrib><creatorcontrib>OH, UH TAEK</creatorcontrib><creatorcontrib>SHIN, SONG SEOK</creatorcontrib><creatorcontrib>PARK, YOUNG-HO</creatorcontrib><title>NOVEL COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME</title><description>This present invention relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1) antagonist; and a pharmaceutical composition containing the same. The present invention provides a pharmaceutical composition for preventing or treating a disease such as pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorder, urinary bladder hypersensitiveness, irritable bowel syndrome, fecal urgency, a respiratory disorder, irritation of skin, eye or mucous membrane, stomach-duodenal ulcer, inflammatory diseases, ear disease, and heart disease.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjT0KwkAQhdNYiHqHuYBFCP6A1biZJAubmSW7CViFIGslGogn8cSuaGVlNe_B976ZJ0-Wjgwoqa20nDuQBmyFTY2KWq8VGnMCVIqsx6MhcGi8A19RQ1IAOuiQtTGic2joTcU9ssdSWDt_iDn_8X1-Oe21sIslwpo1l29p1Ne0TGaX4TqF1fcuEijIq2odxnsfpnE4h1t49GTT_TbNNjtMsz-QF6XeQTc</recordid><startdate>20071205</startdate><enddate>20071205</enddate><creator>KIM, HEE-DOO</creator><creator>PARK, SEOL RIN</creator><creator>KIM, SUNG-IL</creator><creator>LEE, KI-WHA</creator><creator>MOH, JOO HYUN</creator><creator>LIM, KYUNG MIN</creator><creator>WOO, BYOUNG YOUNG</creator><creator>CHOI, JIN KYU</creator><creator>KIM, JOO HYUN</creator><creator>SUH,YOUNG-GER</creator><creator>JEONG, YEON SU</creator><creator>KIM, JIN KWAN</creator><creator>KOH, HYUN JU</creator><creator>JANG, MI JUNG</creator><creator>KIM, SUN-YOUNG</creator><creator>PARK, HYEUNG-GEUN</creator><creator>OH, UH TAEK</creator><creator>SHIN, SONG SEOK</creator><creator>PARK, YOUNG-HO</creator><scope>EVB</scope></search><sort><creationdate>20071205</creationdate><title>NOVEL COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME</title><author>KIM, HEE-DOO ; PARK, SEOL RIN ; KIM, SUNG-IL ; LEE, KI-WHA ; MOH, JOO HYUN ; LIM, KYUNG MIN ; WOO, BYOUNG YOUNG ; CHOI, JIN KYU ; KIM, JOO HYUN ; SUH,YOUNG-GER ; JEONG, YEON SU ; KIM, JIN KWAN ; KOH, HYUN JU ; JANG, MI JUNG ; KIM, SUN-YOUNG ; PARK, HYEUNG-GEUN ; OH, UH TAEK ; SHIN, SONG SEOK ; PARK, YOUNG-HO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP1861357A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2007</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>KIM, HEE-DOO</creatorcontrib><creatorcontrib>PARK, SEOL RIN</creatorcontrib><creatorcontrib>KIM, SUNG-IL</creatorcontrib><creatorcontrib>LEE, KI-WHA</creatorcontrib><creatorcontrib>MOH, JOO HYUN</creatorcontrib><creatorcontrib>LIM, KYUNG MIN</creatorcontrib><creatorcontrib>WOO, BYOUNG YOUNG</creatorcontrib><creatorcontrib>CHOI, JIN KYU</creatorcontrib><creatorcontrib>KIM, JOO HYUN</creatorcontrib><creatorcontrib>SUH,YOUNG-GER</creatorcontrib><creatorcontrib>JEONG, YEON SU</creatorcontrib><creatorcontrib>KIM, JIN KWAN</creatorcontrib><creatorcontrib>KOH, HYUN JU</creatorcontrib><creatorcontrib>JANG, MI JUNG</creatorcontrib><creatorcontrib>KIM, SUN-YOUNG</creatorcontrib><creatorcontrib>PARK, HYEUNG-GEUN</creatorcontrib><creatorcontrib>OH, UH TAEK</creatorcontrib><creatorcontrib>SHIN, SONG SEOK</creatorcontrib><creatorcontrib>PARK, YOUNG-HO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KIM, HEE-DOO</au><au>PARK, SEOL RIN</au><au>KIM, SUNG-IL</au><au>LEE, KI-WHA</au><au>MOH, JOO HYUN</au><au>LIM, KYUNG MIN</au><au>WOO, BYOUNG YOUNG</au><au>CHOI, JIN KYU</au><au>KIM, JOO HYUN</au><au>SUH,YOUNG-GER</au><au>JEONG, YEON SU</au><au>KIM, JIN KWAN</au><au>KOH, HYUN JU</au><au>JANG, MI JUNG</au><au>KIM, SUN-YOUNG</au><au>PARK, HYEUNG-GEUN</au><au>OH, UH TAEK</au><au>SHIN, SONG SEOK</au><au>PARK, YOUNG-HO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NOVEL COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME</title><date>2007-12-05</date><risdate>2007</risdate><abstract>This present invention relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1) antagonist; and a pharmaceutical composition containing the same. The present invention provides a pharmaceutical composition for preventing or treating a disease such as pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorder, urinary bladder hypersensitiveness, irritable bowel syndrome, fecal urgency, a respiratory disorder, irritation of skin, eye or mucous membrane, stomach-duodenal ulcer, inflammatory diseases, ear disease, and heart disease.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP1861357A1
source esp@cenet
subjects ACYCLIC OR CARBOCYCLIC COMPOUNDS
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title NOVEL COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T04%3A22%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KIM,%20HEE-DOO&rft.date=2007-12-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP1861357A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true